BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 23596972)

  • 1. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
    Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
    Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tableting and tablet properties of Kollidon SR: the influence of moisture and mixtures with theophylline monohydrate.
    Hauschild K; Picker-Freyer KM
    Pharm Dev Technol; 2006 Feb; 11(1):125-40. PubMed ID: 16544916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of chitosan acetate as a binder for sustained release tablets.
    Nunthanid J; Laungtana-Anan M; Sriamornsak P; Limmatvapirat S; Puttipipatkhachorn S; Lim LY; Khor E
    J Control Release; 2004 Sep; 99(1):15-26. PubMed ID: 15342177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study of the physical stability of tablets prepared from powders stored under tropical conditions.
    York P
    Pharmazie; 1976 Jun; 31(6):383-6. PubMed ID: 959298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance.
    Buys GM; du Plessis LH; Marais AF; Kotze AF; Hamman JH
    Curr Drug Deliv; 2013 Jun; 10(3):348-56. PubMed ID: 23545146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
    Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
    Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
    Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
    Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the variation in the ambient moisture on the compaction behavior of powder undergoing roller-compaction and on the characteristics of tablets produced from the post-milled granules.
    Gupta A; Peck GE; Miller RW; Morris KR
    J Pharm Sci; 2005 Oct; 94(10):2314-26. PubMed ID: 16136545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
    ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
    Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of moisture and pressure on tablet compaction studied with FTIR spectroscopic imaging.
    Elkhider N; Chan KL; Kazarian SG
    J Pharm Sci; 2007 Feb; 96(2):351-60. PubMed ID: 17080419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of melt granulation technology to enhance stability of a moisture sensitive immediate-release drug product.
    Kowalski J; Kalb O; Joshi YM; Serajuddin AT
    Int J Pharm; 2009 Oct; 381(1):56-61. PubMed ID: 19486933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microparticle surface layering through dry coating: impact of moisture content and process parameters on the properties of orally disintegrating tablets.
    Alyami H; Koner J; Dahmash EZ; Bowen J; Terry D; Mohammed AR
    J Pharm Pharmacol; 2017 Jul; 69(7):807-822. PubMed ID: 27696423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapidly disintegrating tablets prepared by the wet compression method: mechanism and optimization.
    Bi Y; Yonezawa Y; Sunada H
    J Pharm Sci; 1999 Oct; 88(10):1004-10. PubMed ID: 10514347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlating bilayer tablet delamination tendencies to micro-environmental thermodynamic conditions during pan coating.
    Zacour BM; Pandey P; Subramanian G; Gao JZ; Nikfar F
    Drug Dev Ind Pharm; 2014 Jun; 40(6):829-37. PubMed ID: 23638984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of medicines stored together in multi-compartment compliance aids.
    Donyai P
    J Clin Pharm Ther; 2010 Oct; 35(5):533-43. PubMed ID: 20831678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy.
    Otsuka Y; Yamamoto M; Tanaka H; Otsuka M
    Biomed Mater Eng; 2015; 25(3):223-36. PubMed ID: 26407109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time monitoring of changes of adsorbed and crystalline water contents in tablet formulation powder containing theophylline anhydrate at various temperatures during agitated granulation by near-infrared spectroscopy.
    Otsuka M; Kanai Y; Hattori Y
    J Pharm Sci; 2014 Sep; 103(9):2924-2936. PubMed ID: 24832393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.